10x Genomics (TXG) total assets

Total assets · fiscal 2025
$1.04B

10x Genomics (TXG) had total assets of $1.04B at the end of fiscal 2025 (December 31, 2025). That is 13.4% higher than the $918.64M of fiscal 2024. Figures as of 18 Nov 2026, 05:39 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total assets, fiscal 2025
$1.04B
Change on fiscal 2024
+13.4%
Growth, 5 years
+2.3% a year
Highest on record
$1.04Bfiscal 2025
Lowest on record
$124.31Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

10x Genomics total assets, in more detail

Over the five fiscal years to 2025 total assets grew at a compound 2.3% a year. Across the 8 fiscal years on record (2018–2025), the highest was $1.04B in fiscal 2025 and the lowest $124.31M in fiscal 2018.

History · 8 fiscal years

Total assets by fiscal year

10x Genomics total assets, year by year

10x Genomics (TXG) total assets by fiscal year
Fiscal yearTotal assetsChangeYear ended
2025$1.04B 13.4% up
2024$918.64M 4.8% down
2023$965.14M 6.2% down
2022$1.03B 1.0% up
2021$1.02B 9.6% up
2020$929.34M 53.4% up
2019$605.92M 387.4% up
2018$124.31M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

How to read it

It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.

Total assets at health care companies of similar size

Total assets of 10x Genomics and comparable companies
CompanyTotal assetsFiscal year
Twist Bioscience TWST$1.12B2026
Protagonist Therapeutics PTGX$668.19M2025
Krystal Biotech KRYS$1.33B2025
10x Genomics TXG$1.04B2025
HealthEquity HQY$3.38B2026
Corcept Therapeutics CORT$836.65M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on TXG

10x Genomics, figure by figure

10x Genomics (TXG) overview: price, valuation and scorecardAll health care companies by market value

10x Genomics total assets: questions and answers

How large are 10x Genomics's total assets?

10x Genomics (TXG) had total assets of $1.04B at the end of fiscal 2025 (December 31, 2025). That is 13.4% higher than the $918.64M of fiscal 2024.

What is the growth rate of 10x Genomics's total assets?

Over the five fiscal years to 2025 total assets grew at a compound 2.3% a year.

What are the highest and lowest total assets figures on record for 10x Genomics?

Across the 8 fiscal years on record (2018–2025), the highest was $1.04B in fiscal 2025 and the lowest $124.31M in fiscal 2018.

How is 10x Genomics's total assets calculated?

Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “10x Genomics (TXG) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/TXG/total-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.